Astrea breadcrumb logo

Prenatal screening


The Noninvasive Prenatal Test (NIPT) is a maternal blood test performed after 11 gestational weeks, used to check the DNA of the baby. 

This test is used to identify the following syndromes: trisomy 13 (Patau syndrome), trisomy 18 (Edwards’ syndrome), trisomy 21 (Down syndrome). You can also choose to screen for other chromosomal abnormalities.